论文部分内容阅读
目的:探讨我国目前的不良反应补偿体系的建设情况。方法:本研究通过文献调研和电话随访的方式了解我国现行的药品不良反应补偿体系。结果:我国现有的不良反应体系主要为司法救济制度,这种制度尚不能有限的解决药品不良反应的赔偿纠纷问题。结论:应通过建立药品不良反应的社会救济制度来完善我国药品不良反应补偿体系,使消费者的合法权益能够得到及时的维护,使制药企业能够专注于药品质量的改善和新药的研发。
Objective: To explore the current situation of China’s adverse reaction compensation system. Methods: This study through the literature research and telephone follow-up to understand China’s current system of adverse drug reactions compensation. Results: The existing system of adverse reactions in our country is mainly judicial relief system. This system can not solve the problem of compensation disputes of adverse drug reactions. Conclusion: The system of compensation for adverse drug reactions in our country should be perfected through the establishment of a social relief system for adverse drug reactions so that the legitimate rights and interests of consumers can be promptly maintained, enabling pharmaceutical companies to focus on the improvement of drug quality and the development of new drugs.